Back to Search
Start Over
Abnormal expression of four novel molecular markers represents a highly aggressive phenotype in breast cancer. Immunohistochemical assay of p53, nm23, erbB-2, and cathepsin D protein.
- Source :
-
Journal of surgical oncology [J Surg Oncol] 1997 May; Vol. 65 (1), pp. 22-7. - Publication Year :
- 1997
-
Abstract
- Background: In view of the cumulative results to date, p53, nm23, erbB-2, and cathepsin D are the most promising investigational prognostic factors in breast cancer.<br />Objectives: The clinical utility of these molecular markers to predict recurrence was evaluated.<br />Methods: Archival pathology tissues of 100 breast cancer patients were analyzed by immunohistochemical assay. Molecular biologic data were merged with clinicopathologic variables.<br />Results: Thirty-two patients (32%) had recurrence of disease at a median follow-up of 48 months (range 26-72 months). Investigational factor expression had statistical correlation for recurrence with increasing coexpression: one variable 20.6%, two variables 34.2%, three variables 47.1%, four variables 80.0% (P = 0.003). In univariate analysis, lymph node metastasis, tumor size, erbB-2 protein overexpression, and loss of nm23 protein expression were significant variables to determine recurrence; in multivariate analysis, node status and tumor size emerged as the most significant variables for recurrence.<br />Conclusions: Coexpression of the studied investigational variables functioned as significant prognostic correlates for recurrence. These findings suggest that the studied investigational prognostic factors possess the ability to discriminate a highly aggressive phenotype in breast cancer.
- Subjects :
- Breast Neoplasms genetics
Breast Neoplasms pathology
Cathepsin D genetics
Female
Humans
Immunohistochemistry
Middle Aged
Multivariate Analysis
NM23 Nucleoside Diphosphate Kinases
Neoplasm Recurrence, Local metabolism
Phenotype
Prognosis
Receptor, ErbB-2 genetics
Receptors, Estrogen metabolism
Transcription Factors genetics
Tumor Suppressor Protein p53 genetics
Biomarkers, Tumor metabolism
Breast Neoplasms metabolism
Cathepsin D metabolism
Monomeric GTP-Binding Proteins
Nucleoside-Diphosphate Kinase
Receptor, ErbB-2 metabolism
Transcription Factors metabolism
Tumor Suppressor Protein p53 metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 0022-4790
- Volume :
- 65
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Journal of surgical oncology
- Publication Type :
- Academic Journal
- Accession number :
- 9179263
- Full Text :
- https://doi.org/10.1002/(sici)1096-9098(199705)65:1<22::aid-jso5>3.0.co;2-q